Patents by Inventor Evangelia Vakalopoulou

Evangelia Vakalopoulou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Epidermal growth factor receptor antibodies
    Patent number: 6129915
    Abstract: The present invention is related to single and double chain antibodies to EGF receptor. The invention also relates to toxin conjugates of such antibodies. These antibodies are useful for treating and diagnosing the status of pathological conditions such as cancer and cellular hyper proliferation.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: October 10, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Winfried S. Wels, Mathias Schmidt, Evangelia Vakalopoulou, Douglas W. Schneider
  • Growth factor receptor antibodies
    Patent number: 5942602
    Abstract: The present invention is related to single and double chain antibodies to EGF receptor. The invention also relates to toxin conjugates of such antibodies. These antibodies are useful for treating and diagnosing the status of pathological conditions such as cancer and cellular hyper proliferation.
    Type: Grant
    Filed: February 13, 1997
    Date of Patent: August 24, 1999
    Assignee: Schering Aktiengessellschaft
    Inventors: Winfried S. Wels, Mathias Schmidt, Evangelia Vakalopoulou, Douglas W Schneider